CHOLANGIOCARCINOMA NON-RESECTABLE
Clinical trials for CHOLANGIOCARCINOMA NON-RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new CHOLANGIOCARCINOMA NON-RESECTABLE trials appear
Sign up with your email to follow new studies for CHOLANGIOCARCINOMA NON-RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver-targeted chemo shows promise for hard-to-treat bile duct cancer
Disease control Recruiting nowThis study tests giving a combination of two chemotherapy drugs directly into the liver artery for people with bile duct cancer that has not spread but cannot be removed by surgery. The goal is to see if this approach can shrink tumors after standard treatment has stopped working…
Matched conditions: CHOLANGIOCARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated May 17, 2026 00:49 UTC
-
Triple therapy shows promise for tough bile duct cancer
Disease control Recruiting nowThis study is for people with bile duct cancer that cannot be removed by surgery. It combines three treatments: radiation beads (Y-90), an immunotherapy drug (durvalumab), and two chemotherapy drugs (gemcitabine and cisplatin). The goal is to see if this mix can slow cancer growt…
Matched conditions: CHOLANGIOCARCINOMA NON-RESECTABLE
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated May 07, 2026 18:38 UTC